JP2022062113A5 - - Google Patents

Download PDF

Info

Publication number
JP2022062113A5
JP2022062113A5 JP2022010034A JP2022010034A JP2022062113A5 JP 2022062113 A5 JP2022062113 A5 JP 2022062113A5 JP 2022010034 A JP2022010034 A JP 2022010034A JP 2022010034 A JP2022010034 A JP 2022010034A JP 2022062113 A5 JP2022062113 A5 JP 2022062113A5
Authority
JP
Japan
Prior art keywords
engineered transaminase
seq
polypeptide sequence
amino acid
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022010034A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022062113A (ja
JP7212972B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2018/034069 external-priority patent/WO2018231462A1/en
Application filed filed Critical
Publication of JP2022062113A publication Critical patent/JP2022062113A/ja
Publication of JP2022062113A5 publication Critical patent/JP2022062113A5/ja
Application granted granted Critical
Publication of JP7212972B2 publication Critical patent/JP7212972B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022010034A 2017-06-14 2022-01-26 産業上の生体触媒作用のための操作されたトランスアミナーゼポリペプチド Active JP7212972B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762519297P 2017-06-14 2017-06-14
US62/519,297 2017-06-14
PCT/US2018/034069 WO2018231462A1 (en) 2017-06-14 2018-05-23 Engineered transaminase polypeptides for industrial biocatalysis
JP2019568657A JP7122009B2 (ja) 2017-06-14 2018-05-23 産業上の生体触媒作用のための操作されたトランスアミナーゼポリペプチド

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019568657A Division JP7122009B2 (ja) 2017-06-14 2018-05-23 産業上の生体触媒作用のための操作されたトランスアミナーゼポリペプチド

Publications (3)

Publication Number Publication Date
JP2022062113A JP2022062113A (ja) 2022-04-19
JP2022062113A5 true JP2022062113A5 (enExample) 2022-09-22
JP7212972B2 JP7212972B2 (ja) 2023-01-26

Family

ID=64660822

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019568657A Active JP7122009B2 (ja) 2017-06-14 2018-05-23 産業上の生体触媒作用のための操作されたトランスアミナーゼポリペプチド
JP2022010034A Active JP7212972B2 (ja) 2017-06-14 2022-01-26 産業上の生体触媒作用のための操作されたトランスアミナーゼポリペプチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019568657A Active JP7122009B2 (ja) 2017-06-14 2018-05-23 産業上の生体触媒作用のための操作されたトランスアミナーゼポリペプチド

Country Status (7)

Country Link
US (3) US11359183B2 (enExample)
EP (1) EP3638688A4 (enExample)
JP (2) JP7122009B2 (enExample)
CN (1) CN111032682B (enExample)
CA (1) CA3064574A1 (enExample)
IL (1) IL271114A (enExample)
WO (1) WO2018231462A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109456952B (zh) * 2018-11-30 2020-08-04 江南大学 一种可催化西他沙星五元环关键中间体的ω-转氨酶突变体
IL296841A (en) 2020-04-10 2022-11-01 Codexis Inc Transaminase transaminase polypeptides
CN112094856B (zh) * 2020-09-23 2023-06-27 国药集团威奇达药业有限公司 一种转氨酶突变体及其在西格列汀合成中的应用
IL301146A (en) * 2020-09-28 2023-05-01 Codexis Inc Engineered biocatalysts and methods for synthesizing chiral amines
CN112430632B (zh) * 2020-11-18 2022-09-13 上海合全药物研发有限公司 2-((反式)-4-氨基环己烷基)异丙醇的制备方法
CN114645027B (zh) * 2020-12-21 2024-12-10 上海合全药物研发有限公司 一种来源于巨大芽孢杆菌的氨基转移酶突变体及其应用
CN112501145A (zh) * 2021-02-04 2021-03-16 凯莱英医药集团（天津）股份有限公司 转氨酶突变体及其应用
CN113481254B (zh) * 2021-06-29 2023-05-26 台州酶易生物技术有限公司 西他列汀中间体的制备方法
IL311268A (en) * 2021-09-15 2024-05-01 Richter Gedeon Nyrt PROCESS TO PRODUCE (1r,4r)-4-SUBSTITUTED CYCLOHEXANE-1-AMINES
CN115851649B (zh) * 2022-04-21 2024-12-03 凯莱英医药集团（天津）股份有限公司 转氨酶突变体及其应用
CN115807046A (zh) * 2022-09-13 2023-03-17 华中科技大学 一种转氨酶催化合成卡巴拉汀药物中间体的方法

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600692A (en) 1983-02-10 1986-07-15 Purification Engineering, Inc. Immobilized cells for preparing phenylalanine
CA1338400C (en) 1983-08-31 1996-06-18 David H. Gelfand Recombinant fungal cellulases
US4518692A (en) 1983-09-01 1985-05-21 Genetics Institute, Inc. Production of L-amino acids by transamination
US4826766A (en) 1985-09-23 1989-05-02 Genetics Institute, Inc. Production of amino acids using coupled aminotransferases
US5316943A (en) 1988-06-14 1994-05-31 Kidman Gene E Racemic conversion of using a transaminase
US4950606A (en) 1989-06-22 1990-08-21 Celgene Corporation Enantiomeric enrichment and stereoselective synthesis of chiral amines
US5169780A (en) 1989-06-22 1992-12-08 Celgene Corporation Enantiomeric enrichment and stereoselective synthesis of chiral amines
US5300437A (en) 1989-06-22 1994-04-05 Celgene Corporation Enantiomeric enrichment and stereoselective synthesis of chiral amines
US5516936A (en) * 1991-04-18 1996-05-14 University Of Georgia Research Foundation, Inc. Inhibitors of kynureninase
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
AU694954B2 (en) 1994-06-03 1998-08-06 Novo Nordisk A/S Purified myceliophthora laccases and nucleic acids encoding same
EP1559776A3 (en) 1994-06-30 2006-01-11 Novozymes Biotech, Inc. Non-toxic, non-toxigenic, non-pathogenic Fusarium expression system and promoters and terminators for use therein
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
EP2261373A3 (en) 1997-01-17 2011-12-14 Codexis Mayflower Holdings, LLC Evolution of whole cells and organisms by recursive sequence recombination
US6265201B1 (en) 1997-01-17 2001-07-24 Regents Of The University Of Minnesota DNA molecules and protein displaying improved triazine compound degrading ability
EP0987332B1 (en) 1997-04-23 2009-08-19 Kaneka Corporation DNA encoding a polypeptide having stereoselective transaminase activity, and transformants comprising said DNA
US6197558B1 (en) 1997-05-19 2001-03-06 Nsc Technologies Transaminase biotransformation process
WO1999029902A1 (en) 1997-12-08 1999-06-17 California Institute Of Technology Method for creating polynucleotide and polypeptide sequences
IL138800A0 (en) 1998-04-02 2001-10-31 Tellus Genetic Resources Inc A method of identifying a plant with a lesion in a gene sequence
CA2325567A1 (en) 1998-05-01 1999-11-11 Maxygen, Inc. Optimization of pest resistance genes using dna shuffling
US6337186B1 (en) 1998-06-17 2002-01-08 Maxygen, Inc. Method for producing polynucleotides with desired properties
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
WO2000009682A1 (en) 1998-08-12 2000-02-24 Maxygen, Inc. Dna shuffling of monooxygenase genes for production of industrial chemicals
EP1117808B1 (en) 1998-10-06 2004-12-29 Mark Aaron Emalfarb Transformation system in the field of filamentous fungal hosts: in chrysosporium
WO2000020573A2 (en) 1998-10-07 2000-04-13 Maxygen, Inc. Dna shuffling to produce nucleic acids for mycotoxin detoxification
EP1129184A1 (en) 1998-11-10 2001-09-05 Maxygen, Inc. Modified adp-glucose pyrophosphorylase for improvement and optimation of plant phenotypes
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
WO2000042560A2 (en) 1999-01-19 2000-07-20 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US20070065838A1 (en) 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
US7873477B1 (en) 2001-08-21 2011-01-18 Codexis Mayflower Holdings, Llc Method and system using systematically varied data libraries
US8457903B1 (en) 1999-01-19 2013-06-04 Codexis Mayflower Holdings, Llc Method and/or apparatus for determining codons
IL144657A0 (en) 1999-02-11 2002-06-30 Maxygen Inc High throughput mass spectrometry
US6365377B1 (en) 1999-03-05 2002-04-02 Maxygen, Inc. Recombination of insertion modified nucleic acids
US6703240B1 (en) 1999-04-13 2004-03-09 Maxygar, Inc. Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
US6686515B1 (en) 1999-11-23 2004-02-03 Maxygen, Inc. Homologous recombination in plants
IL150291A0 (en) 2000-01-11 2002-12-01 Maxygen Inc Integrated systems and methods for diversity generation and screening
EP1272967A2 (en) 2000-03-30 2003-01-08 Maxygen, Inc. In silico cross-over site selection
AU2001249811B2 (en) 2000-04-03 2006-06-08 Maxygen, Inc. Subtilisin variants
AU2003216507A1 (en) 2002-03-01 2003-09-16 Maxygen, Inc. Methods, systems, and software for identifying functional bio-molecules
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
AU2003213846A1 (en) 2002-03-09 2003-09-29 Maxygen, Inc. Optimization of crossover points for directed evolution
US20050009151A1 (en) 2003-07-10 2005-01-13 Pharmacia Corporation Methods for the stereospecific and enantiomeric enrichment of beta-amino acids
CA2533838A1 (en) 2003-08-11 2005-02-24 Codexis, Inc. Improved ketoreductase polypeptides and related polynucleotides
SG178753A1 (en) 2007-02-12 2012-03-29 Codexis Inc Structure-activity relationships
WO2008127646A2 (en) 2007-04-11 2008-10-23 Dsm Ip Assets B.V. Transaminase-based processes for preparation of pregabalin
EP2250594B1 (en) 2008-02-12 2017-04-19 Codexis, Inc. Method of generating an optimized, diverse population of variants
HUE034642T2 (en) 2008-02-12 2018-02-28 Codexis Inc A method for selecting an optimized diverse population of variants
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
EP2285958B1 (en) 2008-06-13 2016-03-09 Codexis, Inc. Method of synthesizing polynucleotide variants
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
DK2385983T3 (en) * 2009-01-08 2018-02-12 Codexis Inc Transaminase POLYPEPTIDES
CN102405281B (zh) 2009-02-26 2015-05-13 科德克希思公司 转氨酶生物催化剂
ES2644992T3 (es) 2009-06-22 2017-12-01 Codexis, Inc. Reacciones de transaminasa
ES2567134T3 (es) 2009-08-05 2016-04-20 Infinity Pharmaceuticals, Inc. Transaminación enzimática de análogos de ciclopamina
CN102725635B (zh) * 2009-11-07 2015-05-20 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
WO2011159910A2 (en) 2010-06-17 2011-12-22 Codexis, Inc. Biocatalysts and methods for the synthesis of (s)-3-(1-aminoethyl)-phenol
US8932836B2 (en) 2010-08-16 2015-01-13 Codexis, Inc. Biocatalysts and methods for the synthesis of (1R,2R)-2-(3,4-dimethoxyphenethoxy)cyclohexanamine
US20120141420A1 (en) * 2010-11-30 2012-06-07 Sygnis Bioscience Gmbh & Co. Kg Targeted delivery of g-csf for the treatment of amyotrophic lateral sclerosis
US9587229B2 (en) 2011-06-24 2017-03-07 Merck Sharp & Dohme Corp. Immobilized transaminases and process for making and using immobilized transaminase
EP2726651B1 (en) 2011-06-28 2018-11-07 Codexis, Inc. Protein variant generation by region shuffling
WO2013142770A1 (en) * 2012-03-23 2013-09-26 Codexis, Inc. Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
WO2013159055A1 (en) 2012-04-20 2013-10-24 Codexis, Inc. Production of fatty alcohols from engineered microorganisms
CN105008528A (zh) * 2012-12-21 2015-10-28 科德克希思公司 用于合成手性胺的工程化的生物催化剂和方法
JP6436541B2 (ja) * 2013-02-28 2018-12-12 コデクシス， インコーポレイテッド 工業的生体触媒作用のための操作されたトランスアミナーゼポリペプチド
PT2978748T (pt) 2013-03-27 2017-07-06 Pfizer Ireland Pharmaceuticals Processo e intermediários para a preparação de pregabalina
EP3008199A4 (en) * 2013-06-12 2017-01-18 Commonwealth Scientific and Industrial Research Organisation Transaminase biocatalysts
ES2744623T3 (es) * 2015-04-16 2020-02-25 Hoffmann La Roche Transaminasas mutantes, así como procedimientos y usos relacionados con las mismas
CN108602785B (zh) * 2015-12-10 2023-08-11 诺华股份有限公司 新的工艺和中间体
US20190249239A1 (en) * 2016-09-12 2019-08-15 Technische Hochschule Wildau Convertible adapters

Similar Documents

Publication Publication Date Title
JP2022062113A5 (enExample)
JP2025004002A5 (enExample)
JP2024028452A5 (enExample)
RU2012122173A (ru) Варианты альбумина
JP2011517931A (ja) アリサイクロバチルス・アシドカルダリウスおよび関連生物体からの好熱性および好熱好酸性グリコシル化遺伝子および酵素、方法
JP2025163285A (ja) 熱安定性が改善したポリエチレンテレフタレート（ｐｅｔ）分解酵素
JP2022530917A (ja) リシン誘導体を効率的に導入するアミノアシル－ｔＲＮＡシンテターゼ
JP2005509420A5 (enExample)
JP2022070902A5 (enExample)
JP2008545393A5 (enExample)
CN117886907B (zh) 一种pht纳米孔突变体蛋白及其应用
CN116836955B (zh) 末端脱氧核苷酸转移酶及其制备方法
JP6302415B2 (ja) ヒト上皮細胞増殖因子の製造方法
JP2004532037A5 (enExample)
CN106701813A (zh) 表达载体及其构建方法与应用
KR20090039239A (ko) 대장균에서 활성형 인간 상피세포 성장인자의 대량제조방법
Deepa et al. Structure of the extended diarrhea-inducing domain of rotavirus enterotoxigenic protein NSP4
JP2013502217A5 (enExample)
CN102747060A (zh) D-氨甲酰水解酶的突变体及其制备方法和应用
KR20230145054A (ko) 조작된 유전자 bbd29_14900의 재조합 균주 및 이의구성 방법 및 적용
JP2002538775A5 (enExample)
CN117511978B (zh) 一种提高外源蛋白表达量的方法
JP4564791B2 (ja) スタテリン融合タンパク質
JPWO2021207200A5 (enExample)
RU2024106024A (ru) Рекомбинантный микроорганизм, используемый для продукции цдф-холина, и способ продукции цдф-холина с использованием указанного рекомбинантного микроорганизма